Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.

Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ.

JAMA Cardiol. 2019 Jun 19. doi: 10.1001/jamacardio.2019.1856. [Epub ahead of print]

PMID:
31215985
2.

Does an Occluded RCA Affect Prognosis in Patients Undergoing PCI or CABG for Left Main Coronary Artery Disease? Analysis From the EXCEL Trial.

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas JD, Kandzari DE, Banning AP, Morice MC, Taggart DP, Sabik JF 3rd, Serruys PW, Kappetein AP, Stone GW.

EuroIntervention. 2019 Jun 11. pii: EIJ-D-19-00263. doi: 10.4244/EIJ-D-19-00263. [Epub ahead of print]

3.

Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease: Analysis from the EXCEL trial.

Doucet S, Jolicœur EM, Serruys PW, Ragosta M 3rd, Kron IL, Scholtz W, Börgermann J, Zhang Y, McAndrew T, Sabik JF 3rd, Kappetein AP, Stone GW.

Am Heart J. 2019 May 4;214:9-17. doi: 10.1016/j.ahj.2019.04.016. [Epub ahead of print]

PMID:
31150791
4.

Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.

Modolo R, Chichareon P, Kogame N, Dressler O, Crowley A, Ben-Yehuda O, Puskas J, Banning A, Taggart DP, Kappetein AP, Sabik JA, Onuma Y, Stone GW, Serruys PW.

J Am Coll Cardiol. 2019 Apr 23;73(15):1877-1886. doi: 10.1016/j.jacc.2018.12.090.

PMID:
30999989
5.

Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.

Milojevic M, Serruys PW, Sabik JF 3rd, Kandzari DE, Schampaert E, van Boven AJ, Horkay F, Ungi I, Mansour S, Banning AP, Taggart DP, Sabaté M, Gershlick AH, Bochenek A, Pomar J, Lembo NJ, Noiseux N, Puskas JD, Crowley A, Kosmidou I, Mehran R, Ben-Yehuda O, Généreux P, Pocock SJ, Simonton CA, Stone GW, Kappetein AP.

J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.

PMID:
30947913
6.

Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.

Head SJ, Reardon MJ, Deeb GM, Van Mieghem NM, Popma JJ, Gleason TG, Williams MR, Radhakrishnan S, Fremes S, Oh JK, Chang Y, Boulware MJ, Kappetein AP.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007396. doi: 10.1161/CIRCINTERVENTIONS.118.007396.

PMID:
30929507
7.

Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.

Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, Kandzari DE, Puskas JD, Morice MC, Taggart DP, Leon MB, Lembo NJ, Brown WM, Simonton CA, Dressler O, Kappetein AP, Sabik JF, Serruys PW, Stone GW.

Eur Heart J. 2019 Mar 28. pii: ehz113. doi: 10.1093/eurheartj/ehz113. [Epub ahead of print]

PMID:
30919909
8.

Improving coronary artery bypass grafting: a systematic review and meta-analysis on the impact of adopting transit-time flow measurement.

Thuijs DJFM, Bekker MWA, Taggart DP, Kappetein AP, Kieser TM, Wendt D, Di Giammarco G, Trachiotis GD, Puskas JD, Head SJ.

Eur J Cardiothorac Surg. 2019 Mar 25. pii: ezz075. doi: 10.1093/ejcts/ezz075. [Epub ahead of print]

PMID:
30907418
9.

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial.

Collet C, Modolo R, Banning A, Kandzari DE, Stables R, Dressler O, Sabik JF, Kappetein AP, Stone GW, Serruys PW.

JACC Cardiovasc Interv. 2019 Feb 25;12(4):411-412. doi: 10.1016/j.jcin.2018.11.027. No abstract available.

PMID:
30784649
10.

Life-long clinical outcome after the first myocardial revascularization procedures: 40-year follow-up after coronary artery bypass grafting and percutaneous coronary intervention in Rotterdam.

Milojevic M, Thuijs DJFM, Head SJ, Domingues CT, Bekker MWA, Zijlstra F, Daemen J, de Jaegere PPT, Kappetein AP, van Domburg RT, Bogers AJJC.

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):852-859. doi: 10.1093/icvts/ivz006.

PMID:
30753554
11.

C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.

Kosmidou I, Redfors B, Chen S, Crowley A, Lembo NJ, Karmpaliotis D, Brown WM 3rd, Maupas E, Durrleman N, Shah A, Reardon MJ, Dressler O, Ben-Yehuda O, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW.

Am Heart J. 2019 Apr;210:49-57. doi: 10.1016/j.ahj.2018.12.013. Epub 2019 Jan 11.

PMID:
30738244
12.

Coronary Bypass Surgery - An ART for Dedicated Surgeons.

Head SJ, Kappetein AP.

N Engl J Med. 2019 Jan 31;380(5):489-491. doi: 10.1056/NEJMe1814681. No abstract available.

PMID:
30699308
13.

Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.

Huang X, Redfors B, Chen S, Liu Y, Ben-Yehuda O, Puskas JD, Kandzari DE, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Sabik JF, Serruys PW, Kappetein AP, Stone GW.

Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1144-1151. doi: 10.1093/ejcts/ezy438.

PMID:
30596978
14.

Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.

Diamond J, Madhavan MV, Sabik JF 3rd, Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008.

PMID:
30573053
15.

Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial.

Chen S, Redfors B, Liu Y, Vrolix M, Macaya C, Ben-Yehuda O, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW.

Coron Artery Dis. 2019 Mar;30(2):143-149. doi: 10.1097/MCA.0000000000000688.

PMID:
30531253
16.

Sutureless versus Stented Bioprostheses for Aortic Valve Replacement: The Randomized PERSIST-AVR Study Design.

Lorusso R, Folliguet T, Shrestha M, Meuris B, Kappetein AP, Roselli E, Klersy C, Nozza M, Verhees L, Larracas C, Goisis G, Fischlein T.

Thorac Cardiovasc Surg. 2018 Nov 29. doi: 10.1055/s-0038-1675847. [Epub ahead of print]

PMID:
30497085
17.

Reply: Stroke Risk Following Anaortic Off-Pump CABG Versus PCI.

Head SJ, Milojevic M, Domanski MJ, Farkouh ME, Kappetein AP.

J Am Coll Cardiol. 2018 Nov 27;72(21):2681. doi: 10.1016/j.jacc.2018.09.033. No abstract available.

PMID:
30466530
18.

Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.

Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O'Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP.

J Am Coll Cardiol. 2018 Oct 30;72(18):2109-2119. doi: 10.1016/j.jacc.2018.07.093.

PMID:
30360820
19.

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.

Kandzari DE, Gershlick AH, Serruys PW, Leon MB, Morice MC, Simonton CA, Lembo NJ, Banning AP, Merkely B, van Boven AJ, Ungi I, Kappetein AP, Sabik JF 3rd, Généreux P, Dressler O, Stone GW.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007007. doi: 10.1161/CIRCINTERVENTIONS.118.007007.

PMID:
30354633
20.

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.

Brener SJ, Serruys PW, Morice MC, Mehran R, Kappetein AP, Sabik JF 3rd, Liu Y, Dressler O, Ben-Yehuda O, Stone GW.

J Am Coll Cardiol. 2018 Oct 23;72(17):2086-2087. doi: 10.1016/j.jacc.2018.07.084. No abstract available.

PMID:
30336833
21.

Interpretation of results of pooled analysis of individual patient data - Authors' reply.

Head SJ, Papageorgiou G, Milojevic M, Stone GW, Kappetein AP.

Lancet. 2018 Sep 8;392(10150):818. doi: 10.1016/S0140-6736(18)31779-3. No abstract available. Erratum in: Lancet. 2018 Oct 13;392(10155):1310.

PMID:
30215376
22.

Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial.

Thuijs DJFM, Head SJ, Stone GW, Puskas JD, Taggart DP, Serruys PW, Dressler O, Crowley A, Brown WM 3rd, Horkay F, Boonstra PW, Bogáts G, Noiseux N, Sabik JF 3rd, Kappetein AP.

Eur J Cardiothorac Surg. 2018 Aug 27. doi: 10.1093/ejcts/ezy291. [Epub ahead of print]

PMID:
30165487
23.

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial.

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice MC, Leon MB, Kandzari DE, Mehran R, Lembo NJ, Banning AP, Merkely B, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW.

EuroIntervention. 2018 Nov 20;14(10):1104-1111. doi: 10.4244/EIJ-D-18-00711.

24.

Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease.

Domingues CT, Milojevic M, Thuijs DJFM, van Mieghem NM, Daemen J, van Domburg RT, Kappetein AP, Head SJ.

Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):206-213. doi: 10.1093/icvts/ivy237.

PMID:
30101313
25.

Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

Giustino G, Mehran R, Serruys PW, Sabik JF 3rd, Milojevic M, Simonton CA, Puskas JD, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Généreux P, Zhang Z, McAndrew T, Redfors B, Ragosta M 3rd, Kron IL, Dressler O, Leon MB, Pocock SJ, Ben-Yehuda O, Kappetein AP, Stone GW.

J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.

PMID:
30092952
26.

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP.

J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.

PMID:
30025574
27.

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial.

Serruys PW, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra PW, Kappetein AP, Onuma Y, Søndergaard L, van Mieghem N.

EuroIntervention. 2018 Oct 20;14(8):877-883. doi: 10.4244/EIJ-D-18-00460.

28.

Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.

Serruys PW, Cavalcante R, Collet C, Kappetein AP, Sabik JF 3rd, Banning AP, Taggart DP, Sabaté M, Pomar J, Boonstra PW, Lembo NJ, Onuma Y, Simonton CA, Morice MC, McAndrew T, Dressler O, Stone GW.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.

PMID:
29976359
29.

Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.

Gershlick AH, Kandzari DE, Banning A, Taggart DP, Morice MC, Lembo NJ, Brown WM 3rd, Banning AP, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Dressler O, Sabik JF 3rd, Serruys PW, Kappetein AP, Stone GW.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1224-1233. doi: 10.1016/j.jcin.2018.03.040.

PMID:
29976358
30.

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.

Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B, Fearon WF, Taggart D, Kappetein AP, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW; Academic Research Consortium.

Eur Heart J. 2018 Jun 14;39(23):2192-2207. doi: 10.1093/eurheartj/ehy223.

PMID:
29897428
31.

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.

Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B, Fearon WF, Taggart D, Kappetein AP, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW; Academic Research Consortium.

Circulation. 2018 Jun 12;137(24):2635-2650. doi: 10.1161/CIRCULATIONAHA.117.029289. Review.

PMID:
29891620
32.

Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.

Collet C, Miyazaki Y, Ryan N, Asano T, Tenekecioglu E, Sonck J, Andreini D, Sabate M, Brugaletta S, Stables RH, Bartorelli A, de Winter RJ, Katagiri Y, Chichareon P, De Maria GL, Suwannasom P, Cavalcante R, Jonker H, Morel MA, Cosyns B, Kappetein AP, Taggart DT, Farooq V, Escaned J, Banning A, Onuma Y, Serruys PW.

J Am Coll Cardiol. 2018 Jun 19;71(24):2756-2769. doi: 10.1016/j.jacc.2018.02.053. Epub 2018 May 22.

PMID:
29802016
33.

One-year outcomes associated with a novel stented bovine pericardial aortic bioprosthesis.

Sabik JF 3rd, Rao V, Lange R, Kappetein AP, Dagenais F, Labrousse L, Bapat V, Moront M, Weissman NJ, Patel HJ, Reardon MJ, Asch FM, Zeng C, Klautz RJM; PERIGON Investigators.

J Thorac Cardiovasc Surg. 2018 Oct;156(4):1368-1377.e5. doi: 10.1016/j.jtcvs.2018.03.171. Epub 2018 Apr 18.

34.

B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease.

Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, Brown WM 3rd, Banning AP, Taggart DP, Serruys PW, Kappetein AP, Sabik JF 3rd, Stone GW.

Circulation. 2018 Jul 31;138(5):469-478. doi: 10.1161/CIRCULATIONAHA.118.033631.

PMID:
29666071
35.

A case-vignette based assessment of patient's perspective on coronary revascularization strategies, the OPINION study.

Masdjedi K, Daemen J, Diletti R, Wilschut J, Utens E, de Jaegere PP, Lemmert ME, Kappetein AP, Zijlstra F, van Domburg R, Van Mieghem NM.

J Cardiol. 2018 Aug;72(2):149-154. doi: 10.1016/j.jjcc.2018.01.009. Epub 2018 Mar 1.

PMID:
29478878
36.

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP.

Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23. Review. Erratum in: Lancet. 2018 Aug 11;392(10146):476.

PMID:
29478841
37.

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

Kosmidou I, Chen S, Kappetein AP, Serruys PW, Gersh BJ, Puskas JD, Kandzari DE, Taggart DP, Morice MC, Buszman PE, Bochenek A, Schampaert E, Pagé P, Sabik JF 3rd, McAndrew T, Redfors B, Ben-Yehuda O, Stone GW.

J Am Coll Cardiol. 2018 Feb 20;71(7):739-748. doi: 10.1016/j.jacc.2017.12.012.

38.

Reply to Gasz.

Milojevic M, Head SJ, Kappetein AP.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):196-197. doi: 10.1093/ejcts/ezy009. No abstract available.

PMID:
29425300
39.

Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.

Pinho-Gomes AC, Azevedo L, Ahn JM, Park SJ, Hamza TH, Farkouh ME, Serruys PW, Milojevic M, Kappetein AP, Stone GW, Lamy A, Fuster V, Taggart DP.

J Am Coll Cardiol. 2018 Feb 13;71(6):591-602. doi: 10.1016/j.jacc.2017.11.068.

40.

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.

Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, Treede H, Sarano ME, Feldman T, Wijeysundera HC, Topilsky Y, Aupart M, Reardon MJ, Mackensen GB, Szeto WY, Kornowski R, Gammie JS, Yoganathan AP, Arbel Y, Borger MA, Simonato M, Reisman M, Makkar RR, Abizaid A, McCabe JM, Dahle G, Aldea GS, Leipsic J, Pibarot P, Moat NE, Mack MJ, Kappetein AP, Leon MB; VIVID (Valve in Valve International Data) Investigators.

Circulation. 2018 Jan 23;137(4):388-399. doi: 10.1161/CIRCULATIONAHA.117.030729. Review.

PMID:
29358344
41.

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.

Milojevic M, Head SJ, Mack MJ, Mohr FW, Morice MC, Dawkins KD, Holmes DR Jr, Serruys PW, Kappetein AP.

EuroIntervention. 2018 May 20;14(1):102-111. doi: 10.4244/EIJ-D-17-00620.

42.

Recognition, assessment and management of the mechanical complications of acute myocardial infarction.

Durko AP, Budde RPJ, Geleijnse ML, Kappetein AP.

Heart. 2018 Jul;104(14):1216-1223. doi: 10.1136/heartjnl-2017-311473. Epub 2017 Nov 16. Review. No abstract available.

PMID:
29146624
43.

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

Baron SJ, Chinnakondepalli K, Magnuson EA, Kandzari DE, Puskas JD, Ben-Yehuda O, van Es GA, Taggart DP, Morice MC, Lembo NJ, Brown WM 3rd, Banning A, Simonton CA, Kappetein AP, Sabik JF, Serruys PW, Stone GW, Cohen DJ; EXCEL Investigators.

J Am Coll Cardiol. 2017 Dec 26;70(25):3113-3122. doi: 10.1016/j.jacc.2017.10.036. Epub 2017 Oct 30.

44.

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Ej West N, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iñiguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es GA, Morel MA, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP.

Eur Heart J. 2017 Nov 7;38(42):3124-3134. doi: 10.1093/eurheartj/ehx512. Erratum in: Eur Heart J. 2018 May 7;39(18):1619.

45.

Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, Lancellotti P, Sondergaard L, Ludman PF, Tamburino C, Piazza N, Hancock J, Mehilli J, Byrne RA, Baumbach A, Kappetein AP, Windecker S, Bax J, Haude M.

Eur Heart J. 2017 Dec 1;38(45):3382-3390. doi: 10.1093/eurheartj/ehx303. No abstract available.

46.

Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.

Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P.

Eur J Cardiothorac Surg. 2017 Sep 1;52(3):418-424. doi: 10.1093/ejcts/ezx283. No abstract available.

47.

Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, Lancellotti P, Sondergaard L, Ludman PF, Tamburino C, Piazza N, Hancock J, Mehilli J, Byrne RA, Baumbach A, Kappetein AP, Windecker S, Bax J, Haude M.

Eur J Cardiothorac Surg. 2017 Sep 1;52(3):408-417. doi: 10.1093/ejcts/ezx244. No abstract available.

48.

Long-term outlook for transcatheter aortic valve replacement.

Durko AP, Osnabrugge RL, Kappetein AP.

Trends Cardiovasc Med. 2018 Apr;28(3):174-183. doi: 10.1016/j.tcm.2017.08.004. Epub 2017 Aug 10. Review.

49.

Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.

Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P.

Eur Heart J. 2017 Jul 21;38(28):2177-2183. doi: 10.1093/eurheartj/ehx370. No abstract available.

50.

Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.

Palmerini T, Serruys P, Kappetein AP, Genereux P, Riva DD, Reggiani LB, Christiansen EH, Holm NR, Thuesen L, Makikallio T, Morice MC, Ahn JM, Park SJ, Thiele H, Boudriot E, Sabatino M, Romanello M, Biondi-Zoccai G, Cavalcante R, Sabik JF, Stone GW.

Am Heart J. 2017 Aug;190:54-63. doi: 10.1016/j.ahj.2017.05.005. Epub 2017 May 18. Review.

PMID:
28760214

Supplemental Content

Loading ...
Support Center